To describe the characteristics of Pseudomonas aeruginosa (P. aeruginosa) in cystic fibrosis (CF) patients with CFTR 11234V in a large kindred family in Qatar, medical and laboratory records were reviewed of 46 patients of CF with CFTR 11234V from 25 families arising from a single large Arab kindred tribe who attended the CF clinic between May 2002 and June 2008. Thirty eight CF patients, who were negative for P. aeruginosa at first lower respiratory culture, were enrolled in the study. The diagnosis of CF was confirmed by sweat test and molecular genetic study. Trypticase soy agar with 5% sheep blood, McConkey agar, oxidative-fermentative polymyxin B-bacitracin lactose agar, Hemophilus isolation agar and mannitol salt agar were used as selective media for the isolation of important CF respiratory pathogens.
To describe the characteristics of Pseudomonas aeruginosa (P. aeruginosa) in cystic fibrosis (CF) patients with CFTR 11234V in a large kindred family in Qatar, medical and laboratory records were reviewed of 46 patients of CF with CFTR 11234V from 25 families arising from a single large Arab kindred tribe who attended the CF clinic between May 2002 and June 2008. Thirty eight CF patients, who were negative for P. aeruginosa at first lower respiratory culture, were enrolled in the study. The diagnosis of CF was confirmed by sweat test and molecular genetic study. Trypticase soy agar with 5% sheep blood, McConkey agar, oxidative-fermentative polymyxin B-bacitracin lactose agar, Hemophilus isolation agar and mannitol salt agar were used as selective media for the isolation of important CF respiratory pathogens.
The prevalence of (P. aeruginosa) in lower respiratory cultures from 46 patients was 60.9%. Twenty (52.6%) of 38 CF patients with CFTR 11 234V acquired P\ aeruginosa with no seasonal variation. Positive siblings with P. aeruginosa were found in 70% indicating cross-infection within the family. The median (range) age at first detection of P. aeruginosa was 12.5 (1 -19) years. There was no significant difference between males and females in acquisition of P. aeruginosa. P\ aeruginosa of mucoid phenotype was detected in 11 ( 5 5 % ) of 20 with additional organisms, 5. aureusbe'mg the second isolated organism in nine ( 8 1 . 8 % ) of the 11.
Conclusion: A larger prospective study in a cohort of CF patients with CFTR 11234V in the Arabian Gulf region is required to determine the risk factors for acquisition of P. aeruginosa with early aggressive antipseudomonal therapy.
Introduction:
CF is the most common life-threatening recessive genetic trait among white races (1) . It causes chronic lung disease with recurrent bacterial infections. CF patients acquire a unique set of bacterial pathogens that are frequently isolated from their respiratory tract in an age-dependent sequence.
CF lung disease is characterized by chronic infection by P aeruginosa^ which, within the airways of CF patients, is a well-known determinant of their prognosis (3) . Several studies have demonstrated that once P aeruginosa s established within the lungs of CF patients, there is an accelerated decline in lung function, quality of life and life-expectancy (5_7) .
P aeruginosa is an ubiquitous environmental organism and important pathogen in CF (2 ' 3) . The prevalence of P aeruginosa infection increases with age, with positive respiratory tract cultures reported for as many as 20% to 30% of infants, 30% to 40% of children two to ten years of age, about 60% of adolescents, and approximately 80% of adults with CF (1) . The course of P aeruginosa infection in most CF patients has three distinct stages: no P. aeruginosa; initial non-mucoid P. aeruginosa; and mucoid P. aeruginosa colonization (4) . CFTR 11234V mutation is one of the most common mutations among Arabs in the Gulf region, arising from a single large Arab kindred tribe (8/9) . This mutation is associated with normal exocrine pancreatic function based on no history of malabsorption and normal levels of fecal elastase-1 (10) .
Respiratory microbiology has been reported with this mutation (11} but the prevalence and age at acquisition of P. aeruginosa have not been reported yet in Qatar. The primary endpoint of this study was to determine the prevalence of P. aeruginosasnd the age at initial acquisition from lower respiratory secretions culture-negative to culture positive for P aeruginosa of CF patients who were followed between 2002 and 2008.
Methods:
Following ethical clearance from the Research Committee, Medical Research Centre, we examined all CF patients with CFTR 11234V who were followed from May 2002 to June 2008. They were registered within a clinical database and electronic laboratory database in the Department of Pediatrics at Hamad Medical Corporation (HMC). The diagnosis of CF was confirmed by pilocarpine iontophoresis sweat test (sweat chloride >60 mmol/L) on two occasions and molecular genetic study. All CF patients with CFTR 11234V were selected for analysis if they had two or more culture results available in the electronic laboratory database, the first of which was negative for P. aeruginosa. None of CF patients received anti-staphylococcal prophylaxis and none had a history of meconium ileus. Ant\-pseudomonas antibiotics were given to the patients with positive cultures of the lower respiratory secretions obtained from deep throat samples, sputum or broncho-alveolar lavage.
In the Microbiology Laboratory, HMC, samples were plated on selective media for isolation of important CF pathogens: Trypticase soy agar with 5% sheep blood, McConkey agar, oxidative-fermentative polymyxin Bbacitracin lactose agar, Haemophilus isolation agar and manitol mannitol salt agar. Organisms were identified by standard techniques, including the use of biochemical panels. In addition to P aeruginosa, other organisms which were selectively cultured and identified included 5. aureus, Haemophilus influenzae, Stenotrophomonas maltophilia, Achromobacter xylosoxidans, Enterobacteriaceae, and Burkholderia species in the B. cepacia complex.
CFTR 11 234V was detected by a molecular genetic test using PCR and Ddel restriction fragment analysis.
Spirometry tests including forced expiratory volume in the first second (FEV1), forced vital capacity (FVC), and mid-peak flows (FEF 25-75) measured with a flow-sensing spirometer (Sensor Medicus Model V6200, German) and determined by standard spirometry meeting American Thoracic Society criteria . Absolute values were converted to a percentage of the predicted volume expected for a healthy individual of the same age, sex, and height. The measurements were taken at the time of P aeruginosa acquisition.
The Statistical Package for Social Sciences (SPSS) version 14.0 was used for data entry and statistical analysis. Descriptive statistics were calculated for all continuous and categorical for the data. Chi-square tests and nonparametric wilcoxon's rank sum test were performed to see significant differences between positive and negative P aeruginosa; p<0.05 was considered statistically significant.
Results:
The study subjects consisted of 46 CF patients with CFTR 11234V arising from a single large Arab kindred tribe from 25 families attending the CF Clinic between May 2002 and June 2008 at the Pediatrics Department, HMC, Qatar, of whom there were five CF sibling pairs, three families with three CF siblings, two families with four and one family with five. The median (range) age was 13.8 (2.5-32.6) years. The overall prevalence of P. aeruginosa was 28 out of 46 CF patients (60.9%). Eight patients, who were positive for P. aeruginosa s 2002 at first culture were excluded from the study. The remaining 38 CF patients were followed in the study. Table 1 1 shows the clinical characteristics of these two cohorts. Although similar by genotype, those who were positive for P aeruginosa at the first culture tended to be mostly males. The median number of cultures per patient was 19, collected over a follow-up of six years. Descriptive data of the study CF cohort, who were negative for P aeruginosas first culture, at baseline are (39.5% of the patients harbored 5. aureus and H. influenza at first culture, while 10.5% harbored three organisms).
Twenty patients (52.6%) acquired P. aeruginosa with no seasonal variation due to the small number of patients and no identifiable pattern. Positive siblings with P aeruginosa were found in 70%. The median (range) age at first detection of P aeruginosa was 12.5 (1-19) years. P. aeruginosa was the only organism in three CF patients (1 5%), with H. influenza being the most common (n=5, 25%). For lung function measurements, the value measured at or before acquiring P. aeruginosa culture date was available only in 13 patients (Table 3) . There was no significant difference between males and females in the median age at diagnosis, age of P aeruginosa acquisition, but was significantly higher for females in both FEV1 and FEF25-75 (Table 4) .
Univariate analysis of the association between each potential risk factor such as gender, and infection with S. aureus was not significantly associated with elevated risk of P. aeruginosa acquisition, and is not presented in the results. P aeruginosa of mucoid phenotype was detected in 11 of 20 CF patients (55%); with additional organism with S. aureus being the most common organism in 9 of 11 CF patients (81.8%) with no seasonal variation. The median (range) age at time of acquired mucoid P aeruginosa was 14. in five CF patients (45.5%). It was detected in 11 of 20 CF patients (55%) five of whom (45%) were male. The median duration of the phenotypic changes from initial non-mucoid P. aeruginosaXo mucoid P aeruginosa was 20 months (range 1 -60 months). All the CF patients in this cohort are still alive.
Discussion:
In the present study we investigated an initial acquisition of P. aeruginosa s a small cohort of CF patients with CFTR 11234V arising from a single large Arab kindred tribe from 25 families associated with pancreatic sufficiency aiming to look for the potentially attributable risk of acquiring P. aeruginosa. Our study showed that CF siblings are often infected. This may explain the high prevalence of P. aeruginosa in the respiratory tract cultures in our series of CF patients during the six-year period (60.9%) and is most probably explained by cross-infection within the family. This finding is in agreement with other previous reports (12, 13) . We found that the airway of a CF patient does become colonized by progression from no P. aeruginosa, initial nonmucoid P. aeruginosa, and then mucoid P. aeruginosa, confirming the reports of previous studies (4) .
In addition and more importantly we found an association between more frequent positive S. aureus cultures and existing infection with mucoid P. aeruginosa. This finding contradicts the results of previous studies which found that a lifetime history of S. aureus infection and a recent history of S. aureus infection were associated with a lower risk of acquisition of P. aeruginosa colonization^4^ Several studies have reported that earlier acquisition of P. aeruginosa has a deleterious effect on the clinical course or has a more severe impact of P. aeruginosa in female patients^1 4, 15) . Our results demonstrated no significant difference in the probability distributions of males and females of initial positive culture for P aeruginosa and even females had better percent and predicted forced expiatory volume in one second. Eleven of 20 CF patients with P. aeruginosa in lower respiratory secretion converted to mucoid type and showed no difference between genders. This may be explained by too few participants in the present study to determine any significant difference between genders.
In summary, our results demonstrated 52.6% of CF patients with CFTR 11234V, mainly CF siblings, with person-to-person transmission and no difference between genders. A larger prospective study in a cohort of CF patients with CFTR 11234V in the Arabian Gulf region is required to determine the risk factors for acquisition of P. aeruginosaand whether early aggressive treatment can eradicate the pulmonary infection.
